Global Abuse Deterrent Formulation Technology Market, Trends & Analysis - Forecasts to 2026

1. Global Abuse Deterrent Formulation Technology Market, Trends & Analysis - Forecasts to 2026 By Product (Embolization Devices, Revascularization Devices, Accessory Devices, Thrombectomy Devices, Embolic Protection Devices), By Disease Pathology (Aneurysm, Arteriovenous Malformation, Ischemic Stroke, Stenosis), By Region (North America, Europe, Asia Pacific and Rest of the World); Vendor Landscape, End User Landscape and Company Market Share Analysis & Competitor Analysis Abuse Deterrent Formulation Technology Market [2019-2026] The global abuse deterrent formulation technology market is estimated to witness a moderate CAGR during the forecast period. Abuse deterrent formulation technology is the method to minimize prescribed drug abuse while ensuring total access to vital medications for individuals with legitimate needs. The demand for abuse deterrent formulation technology is driven by growing number of drug misuse cases that occur every year across the globe. According to the Centers for Disease Control and Prevention (CDC), more than 72,000 overdose-related deaths were reported in America only in the year 2017. Rising health issues, increasing cases of operations and the growing geriatric population are also expected to boost the use of abuse deterrent formulation technology. Prescription drug abuse affects people of all ages, education, income level, gender, and ethnic background around the world. The continuous research & development in the healthcare sector to stop the drug overdose is expected to boost the global abuse deterrent formulation technology market. However, lack of awareness about drug overdose and complex molecular structure of the drugs are expected to restrain the growth of the global abuse deterrent formulation technology market. Global Abuse Deterrent Formulation Technology Market Size

2. Request for a sample copy of Global Abuse Deterrent Formulation Technology Market at: https://www.globalmarketestimates.com/report- summary.php?report_id=1647&report_name=global-abuse-deterrent-formulation- technology-market Global Abuse Deterrent Formulation Technology Market: Opioids is expected to have largest market share [2019-2026] The opioids segment is expected to have the largest market share in the drug segment. Serious attempts to reduce the abuse of prescription drugs, most notably opioids, have been ongoing for more than a decade with some significant advancement being made recently. It was estimated that more than 50,000 cases of deaths were reported in the U.S alone by the overdose of opioids. Also misuse of benzodiazepines, including Valium (diazepam) and Xanan (alprazolam) are gaining popularity across the globe. Growth of the global abuse deterrent formulation technology market is due to the fact that increasing healthcare expenditure and research & development activities in the field of healthcare industry. Global Abuse Deterrent Formulation Technology Market: Abuse-Deterrent Drug Delivery Systems is expected is expected to grow at the highest CAGR [2019-2026] The abuse-deterrent drug delivery systems is expected to grow at the highest CAGR in the abuse deterrence approach segment during the forecast period. It is estimated by the National Survey on Drug Use and Health (NSDUH) that an increasing number of individuals aged 15 or older have abused illicit and/or prescription drugs due to which it is more important to stop the abuse as it hampers the social phycology of the person and the person becomes an addict with the drug. Abuse-deterrent drug delivery systems have been proven to minimize prescribed drug abuse and its consequences. The minimal effect in abuse can have a significant impact on the people by reducing the costly social, physical, mental, and public health problems resulting from abuse. Global Abuse Deterrent Formulation Technology Market: Tablets is expected to have largest market share [2019-2026] The tablets segment is expected to have the largest market share for the end product segment. Since all dosage forms have been subjected to abuse, liquid have been particularly attractive to the abuser due to the high drug content incorporated in these dosage forms with the intent of ensuring long term pain relief when used as prescribed. When the dosage forms are tampered with and administered through one of the common routes, they often lead to an instant release of the drug, which, in turn, provides abusers with the euphoria that they desperately desire. To prevent this addictions tablets are given to the patients which are very common. Global Abuse Deterrent Formulation Technology Market: North America is expected to dominate the market [2019-2026] North America is expected to dominate the market of global abuse deterrent formulation technology over the forecast period, owing to presence of leading manufactures in this region including Bayer, TITAN Pharmaceuticals, Pfizer, Orexo, and Lonza among others. The market growth in the region is attributed to multiple factors such as more cases of drug overdose and illegal possession of drugs like morphine, hash and heroine among others. The market for abuse deterrent formulation technology in the region is majorly dominated by U.S. and Canada. Recent advancement in the drug manufacturing including tamper-resistant dosage forms which resist

3. chewing, cutting, crushing, milling, extraction and concomitant ingestion of tablets with or without alcohol is also expected to spur the market of abuse deterrent formulation technology in the region. Abuse Deterrent Formulation Technology Market: End Use Landscape The end-user landscape entails a list of current and prospective consumers prevailing across the regions. This section briefs you about company addresses, contact details, products, and regional presence of companies who are purchasing or are likely to purchase. The key end-users of the markets are Sun Pharma, Cima Labs and Acura Pharmaceuticals among others. Abuse Deterrent Formulation Technology Market: Vendor Landscape The report contains a chapter dedicated to vendors operating in the market, covering raw material manufactures, equipment developers, manufacturers, and distributors. The report provides these insights on a regional level. This section of the report entails contact details, experience, products manufactured/supplied, and geographical presence of companies. Abuse Deterrent Formulation Technology Market Share & Competitor Analysis Some of the key players operating in the abuse deterrent formulation technology market are Bayer, TITAN Pharmaceuticals, Pfizer, Orexo, Lonza, Johnson & Johnson, Acura Pharmaceuticals, Daiichi Sankyo, ExxPharma Therapeutics, SunGen Pharma and Teva Pharmaceutical among others. In October 2019, Capsule Delivery Solutions which is a subsidiary of Lonza Pharma & Biotech, showcased its diverse portfolio of Capsugel, capsules and technologies designed to support drug development at the annual CPhI Worldwide 2019. In August 2019, Pfizer announced that US FDA their drug TROXYCA capsules, for oral use to reduce abuse of long-term opioid treatment. In September 2017, Orexo and Mundipharma International launched fast-dissolving Zubsolv buprenorphine and naloxone sublingual tablet to treat people with opioid use disorder. Browse the full report at: https://www.globalmarketestimates.com/report- summary.php?report_id=1647&report_name=global-abuse-deterrent-formulation-technology- market